Top Markets
Coin of the day
OKYO Pharma Limited OKYO Pharma Limited

OKYO Pharma Limited

OKYO
株式のランク #39874
OKYO Pharma Limited, a biopharmaceutical entity operating at the preclinical... OKYO Pharma Limited, a biopharmaceutical entity operating at the preclinical stage, focuses on creating treatments for individuals experiencing inflammatory conditions of the eye and chronic ocular pain. Established in 2007 and headquartered in London, UK, the company's primary investigational drug is OK-101, aimed at addressing dry eye syndrome. Additionally, the firm is advancing OK-201, a preclinical analogue developed from bovine adrenal medulla, designed to alleviate neuropathic ocular pain.
株価
$0.01904982
最終同期: 2023-05-19
時価総額
$316.00K
変化(1日)
-17.05%
変化(1年)
0.00%
GB
取引 OKYO Pharma Limited (OKYO)

カテゴリー

OKYO Pharma Limited(OKYO)の株価履歴
終値の最高値: $0.02 (2023-05-01)

終値の最安値: $0.07 (2018-07-01)
OKYO Pharma Limited の株価履歴(2018 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2023 -21.40%
2022 -68.15%
2021 -2.30%
2020 334.44%
2019 25.96%
2018 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$517.18 32.51%
US
$857.76 31.47%
NL
$744.96 9.07%
CH
$1.07K -6.40%
KR
$259.89 14.81%
BE